We are live on ! Find out more
CMRA

Comera Life Sciences Holdings, Inc. Common Stock
CMRA

Delisted

CMRA was delisted on the 16th of November, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Comera Life Sciences Holdings, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.83% less ownership

Funds ownership: 3.83% → 0% (-3.8%)

100% less funds holding

Funds holding: 14 → 0 (-14)

100% less capital invested

Capital invested by funds: $194K → $0 (-$194K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 14

Holders
–
Holders Change
-14
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Corient Private Wealth
Corient Private Wealth
Florida
-$123K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$22.4K
3
HighTower Advisors
HighTower Advisors
Illinois
-$14K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$12.9K
5
State Street
State Street
Massachusetts
-$9.44K

CMRA Hedge Fund Activity: Q4 2023 in Review

0 of the 6,870 institutional investors tracked by Wall St. Rank reported a position in Comera Life Sciences Holdings, Inc. Common Stock (CMRA) for Q4 2023, worth a combined $0 — down 100% from $194K a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CMRA and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Corient Private Wealth, exiting entirely with an estimated $123K sold.

  • 0 institutional investors held Comera Life Sciences Holdings, Inc. Common Stock (CMRA) as of Q4 2023, down from 14 in Q3 2023.
  • Funds reported $0 of Comera Life Sciences Holdings, Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Comera Life Sciences Holdings, Inc. Common Stock positions in Q4 2023 and 14 closed out, a net change of -14 holders.
  • The largest Comera Life Sciences Holdings, Inc. Common Stock seller in Q4 2023 was Corient Private Wealth, an estimated $123K sold.

Based on aggregated 13F filings for Q4 2023.